BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

539 related articles for article (PubMed ID: 33423918)

  • 1. Clinical validation of quantitative SARS-CoV-2 antigen assays to estimate SARS-CoV-2 viral loads in nasopharyngeal swabs.
    Aoki K; Nagasawa T; Ishii Y; Yagi S; Okuma S; Kashiwagi K; Maeda T; Miyazaki T; Yoshizawa S; Tateda K
    J Infect Chemother; 2021 Apr; 27(4):613-616. PubMed ID: 33423918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of a persistent viral shedding patient infected with SARS-CoV-2 by RT-qPCR, FilmArray Respiratory Panel v2.1, and antigen detection.
    Hirotsu Y; Maejima M; Shibusawa M; Amemiya K; Nagakubo Y; Hosaka K; Sueki H; Hayakawa M; Mochizuki H; Tsutsui T; Kakizaki Y; Miyashita Y; Omata M
    J Infect Chemother; 2021 Feb; 27(2):406-409. PubMed ID: 33183963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid SARS-CoV-2 antigen detection assay in comparison with real-time RT-PCR assay for laboratory diagnosis of COVID-19 in Thailand.
    Chaimayo C; Kaewnaphan B; Tanlieng N; Athipanyasilp N; Sirijatuphat R; Chayakulkeeree M; Angkasekwinai N; Sutthent R; Puangpunngam N; Tharmviboonsri T; Pongraweewan O; Chuthapisith S; Sirivatanauksorn Y; Kantakamalakul W; Horthongkham N
    Virol J; 2020 Nov; 17(1):177. PubMed ID: 33187528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of clinical utility of novel coronavirus antigen detection reagent, Espline® SARS-CoV-2.
    Aoki K; Nagasawa T; Ishii Y; Yagi S; Kashiwagi K; Miyazaki T; Tateda K
    J Infect Chemother; 2021 Feb; 27(2):319-322. PubMed ID: 33388232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective study of 1308 nasopharyngeal swabs from 1033 patients using the LUMIPULSE SARS-CoV-2 antigen test: Comparison with RT-qPCR.
    Hirotsu Y; Maejima M; Shibusawa M; Amemiya K; Nagakubo Y; Hosaka K; Sueki H; Hayakawa M; Mochizuki H; Tsutsui T; Kakizaki Y; Miyashita Y; Omata M
    Int J Infect Dis; 2021 Apr; 105():7-14. PubMed ID: 33556612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current status of the lateral flow immunoassay for the detection of SARS-CoV-2 in nasopharyngeal swabs.
    Somborac Bačura A; Dorotić M; Grošić L; Džimbeg M; Dodig S
    Biochem Med (Zagreb); 2021 Jun; 31(2):020601. PubMed ID: 34140830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison between Nasal and Nasopharyngeal Swabs for SARS-CoV-2 Rapid Antigen Detection in an Asymptomatic Population, and Direct Confirmation by RT-PCR from the Residual Buffer.
    Patriquin G; LeBlanc JJ; Williams C; Hatchette TF; Ross J; Barrett L; Davidson R
    Microbiol Spectr; 2022 Feb; 10(1):e0245521. PubMed ID: 35171010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of a chemiluminescent enzyme immunoassay-based high-throughput SARS-CoV-2 antigen assay for the diagnosis of COVID-19: The VITROS® SARS-CoV-2 Antigen Test.
    Matsuzaki N; Orihara Y; Kodana M; Kitagawa Y; Matsuoka M; Kawamura R; Takeuchi S; Imai K; Tarumoto N; Maesaki S; Maeda T
    J Med Virol; 2021 Dec; 93(12):6778-6781. PubMed ID: 34170555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of automated SARS-CoV-2 antigen test for COVID-19 infection with quantitative RT-PCR using 313 nasopharyngeal swabs, including from seven serially followed patients.
    Hirotsu Y; Maejima M; Shibusawa M; Nagakubo Y; Hosaka K; Amemiya K; Sueki H; Hayakawa M; Mochizuki H; Tsutsui T; Kakizaki Y; Miyashita Y; Yagi S; Kojima S; Omata M
    Int J Infect Dis; 2020 Oct; 99():397-402. PubMed ID: 32800855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of Lumipulse® G SARS-CoV-2 antigen assay automated test for detecting SARS-CoV-2 nucleocapsid protein (NP) in nasopharyngeal swabs for community and population screening.
    Gili A; Paggi R; Russo C; Cenci E; Pietrella D; Graziani A; Stracci F; Mencacci A
    Int J Infect Dis; 2021 Apr; 105():391-396. PubMed ID: 33647511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical assessment of the Roche SARS-CoV-2 rapid antigen test.
    Salvagno GL; Gianfilippi G; Bragantini D; Henry BM; Lippi G
    Diagnosis (Berl); 2021 Aug; 8(3):322-326. PubMed ID: 33554511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analytical performances of the point-of-care SIENNA™ COVID-19 Antigen Rapid Test for the detection of SARS-CoV-2 nucleocapsid protein in nasopharyngeal swabs: A prospective evaluation during the COVID-19 second wave in France.
    Mboumba Bouassa RS; Veyer D; Péré H; Bélec L
    Int J Infect Dis; 2021 May; 106():8-12. PubMed ID: 33746093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic performance of the Elecsys SARS-CoV-2 antigen assay in the clinical routine of a tertiary care hospital: Preliminary results from a single-center evaluation.
    Mueller T; Kompatscher J; La Guardia M
    J Clin Lab Anal; 2021 Aug; 35(8):e23906. PubMed ID: 34251047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid SARS-CoV-2 antigen detection potentiates early diagnosis of COVID-19 disease.
    Lv Y; Ma Y; Si Y; Zhu X; Zhang L; Feng H; Tian D; Liao Y; Liu T; Lu H; Ling Y
    Biosci Trends; 2021 May; 15(2):93-99. PubMed ID: 33776018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative detection of SARS-CoV-2 RNA in nasopharyngeal samples from infected patients with mild disease.
    Bustos P; Tambley C; Acevedo A; Andrade W; Leal G; Vidal D; Roldán F; Fasce R; Ramírez E
    J Med Virol; 2021 Apr; 93(4):2439-2445. PubMed ID: 33368332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accuracy of a nucleocapsid protein antigen rapid test in the diagnosis of SARS-CoV-2 infection.
    Diao B; Wen K; Zhang J; Chen J; Han C; Chen Y; Wang S; Deng G; Zhou H; Wu Y
    Clin Microbiol Infect; 2021 Feb; 27(2):289.e1-289.e4. PubMed ID: 33031947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of Three Immunoassays for the Rapid Detection of SARS-CoV-2 antigens.
    Baccani I; Morecchiato F; Chilleri C; Cervini C; Gori E; Matarrese D; Bassetti A; Bonizzoli M; Mencarini J; Antonelli A; Rossolini GM
    Diagn Microbiol Infect Dis; 2021 Oct; 101(2):115434. PubMed ID: 34174523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time scale performance of rapid antigen testing for SARS-CoV-2: Evaluation of 10 rapid antigen assays.
    Abusrewil Z; Alhudiri IM; Kaal HH; El Meshri SE; Ebrahim FO; Dalyoum T; Efrefer AA; Ibrahim K; Elfghi MB; Abusrewil S; Elzagheid A
    J Med Virol; 2021 Dec; 93(12):6512-6518. PubMed ID: 34241912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic Performance Assessment of Saliva RT-PCR and Nasopharyngeal Antigen for the Detection of SARS-CoV-2 in Peru.
    Calderón RI; Jhaveri TA; Tovar MA; Palomino JS; Barreda NN; Sanabria OM; Peinado J; Ramirez C; Llanos Zavalaga LF; Valderrama G; Franke MF; Mitnick CD; Lecca L; Velásquez GE
    Microbiol Spectr; 2022 Aug; 10(4):e0086122. PubMed ID: 35867471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lower nasopharyngeal viral load during the latest phase of COVID-19 pandemic in a Northern Italy University Hospital.
    Clementi N; Ferrarese R; Tonelli M; Amato V; Racca S; Locatelli M; Lippi G; Silvestri G; Clementi M; Mancini N
    Clin Chem Lab Med; 2020 Aug; 58(9):1573-1577. PubMed ID: 32598306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.